IMP: Plan for collecting shareholders' written opinions

Plan for collecting shareholders' written opinions of Imexpharm Corporation as follows: 

HOSE

>   EIC: Board Resolution (01/10/2024)

>   CAB: Board Resolution (01/10/2024)

>   HOSE: Proprietary Trading (01 Oct 2024) (01/10/2024)

>   HNX: Proprietary trading results on 01/10/2024 (UPCoM) (01/10/2024)

>   HNX: Proprietary trading results on 01/10/2024 (Listed Market) (01/10/2024)

>   VNA: Extraordinary General Mandate 2024 (01/10/2024)

>   CNT: 08/10/2024, first trading date of additional shares on UPCoM (01/10/2024)

>   PSW: Information on loan transactions at the Bank (01/10/2024)

>   LPB123016: Board Resolution (01/10/2024)

>   LPB123016: Board Resolution (01/10/2024)